Advanced Therapies Experiences (Q4295926): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Attach the beneficiary based on the string)
(‎Changed an Item: Adding NUTS from updating NUTS 2021)
Property / contained in NUTS
 
Property / contained in NUTS: Province of Pavia / rank
 
Normal rank
Property / contained in NUTS
 
Property / contained in NUTS: Canton of Ticino / rank
 
Normal rank
Property / contained in NUTS
 
Property / contained in NUTS: Province of Como / rank
 
Normal rank
Property / contained in NUTS
 
Property / contained in NUTS: Province of Novara / rank
 
Normal rank

Revision as of 04:13, 7 September 2022

Project Q4295926 in Switzerland, Italy
Language Label Description Also known as
English
Advanced Therapies Experiences
Project Q4295926 in Switzerland, Italy

    Statements

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    625,977.57 Euro
    0 references
    1,131,053.71 Euro
    0 references
    55.34 percent
    0 references
    16 October 2018
    0 references
    15 October 2021
    0 references
    Università del Piemonte OrientaleDipartimento di Scienze del Farmaco (sede di Novara)|Industrie Biomediche Insubri SA - Mezzovico (Ticino)
    0 references
    0 references

    45°26'48.95"N, 8°37'19.78"E
    0 references

    45°11'4.99"N, 9°9'29.56"E
    0 references

    45°48'29.02"N, 9°5'6.65"E
    0 references

    46°5'22.92"N, 8°55'8.08"E
    0 references
    ATEX project aims at activating a new cross-border platform to transfer innovative ideas to the market in the field of advanced therapies. This knowledge platform intends to translate ideas into advanced products for the treatment of various chronic diseases. Through ATEx, different organizations working between Ticino and Lombardy on the combination of biomaterials of various origins (animal or human) and stem cells or their derivatives will be networked. In particular, the project aims to promote the development of new solutions, identify subjects capable of dealing with regulatory aspects and financing, and systematically transfer this knowledge to the market. (English)
    0 references

    Identifiers

    0 references